Roundtable Discussion: Utilizing Biomarkers to Guide Patient Selection, Predict Responses & Improve Safety

• Exploring predictive patient and donor biomarkers to determine the cell therapy modalities best suited for individual patients and disease contexts
• Identifying pre-infusion and on-treatment biomarker signals to understand response dynamics and guide clinical decision making
• Evaluating immune fitness and safety related biomarkers to identify patients at risk, anticipate challenges, and enhance therapeutic outcomes

Speakers:

Kanya Rajangam

President, Chief Medical Officer & Head of Research & Development

Senti Biosciences Inc.